02/09/2024
7:36 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Velan Capital Investment Management LP (Filed by)
| Form SC 13D/A | |
02/09/2024
7:40 PM | Avego Healthcare Capital Holdings, LLC (Reporting)
Avego Healthcare Capital, L.P. (Reporting)
Avego Management LLC (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Morgan Adam (Reporting)
Velan Capital Holdings LLC (Reporting)
Velan Capital Investment Management LP (Reporting)
Velan Capital Management LLC (Reporting)
Velan Capital Master Fund LP (Reporting)
VENKATARAMAN BALAJI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
8:07 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
8:15 AM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G/A | |
02/02/2024
8:50 AM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
01/04/2024
5:04 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
7:05 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/20/2023
5:06 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
7:14 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:11 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form DEF 14A | |
11/09/2023
3:01 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form PRE 14A | |
11/09/2023
8:18 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
7:05 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
4:58 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
5:00 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
WIGGANS THOMAS G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
7:00 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
5:04 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
5:55 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Lis William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/13/2023
5:56 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Lis William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
5:57 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
MARTELL RON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
5:58 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
10:15 AM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G | |
10/10/2023
6:00 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
5:19 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:14 PM | CROSS HERB (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/26/2023
3:16 PM | CROSS HERB (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2023
7:00 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
7:05 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:05 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:06 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/20/2023
8:47 PM | Brun Scott C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2023
8:48 PM | Brun Scott C. (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
8:09 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Mahal Jeetinder Singh (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
7:45 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Tucker Edwin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:54 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:45 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Tucker Edwin Jonathan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/08/2023
5:41 PM | French Anna Louise (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:42 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Lis William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:42 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Nolet Chris (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:43 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Shizuru Judith Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:43 PM | EMSTER KURT VON (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/08/2023
5:44 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:44 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Kapoor Vishal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2023
11:15 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form EFFECT | |
04/14/2023
3:17 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
MARTELL RON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2023
3:19 PM | EMSTER KURT VON (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2023
3:19 PM | French Anna Louise (Reporting)
Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2023
3:25 PM | French Anna Louise (Reporting)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/13/2023
4:20 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
Lis William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/13/2023
1:33 PM | EMSTER KURT VON (Reporting)
Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2023
6:55 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
MCDADE MARK (Reporting)
Qiming U.S. Healthcare Fund II, L.P. (Reporting)
Qiming U.S. Healthcare GP II, LLC (Reporting)
RIESCHEL GARY E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2023
3:01 PM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form PRE 14A | |
03/20/2023
4:59 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
MARTELL RON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2023
5:00 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Mahal Jeetinder Singh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2023
7:35 PM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Kapoor Vishal (Reporting)
| Form 3/A | |
02/17/2023
7:30 AM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Kapoor Vishal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/17/2023
7:20 AM | Jasper Therapeutics, Inc. (Filer)
Jasper Therapeutics (Filer)
Jasper Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/17/2023
7:25 AM | Jasper Therapeutics, Inc. (Issuer)
Jasper Therapeutics (Issuer)
Jasper Therapeutics, Inc. (Issuer)
Kapoor Vishal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/13/2023
3:49 PM | Jasper Therapeutics, Inc. (Subject)
Jasper Therapeutics (Subject)
Jasper Therapeutics, Inc. (Subject)
ROCHE FINANCE LTD (Filed by)
| Form SC 13G/A | |
